#158413

Anti-insulin-like growth factor-2 mRNA-binding protein 2 [5E10-3E1]

Cat. #158413

Anti-insulin-like growth factor-2 mRNA-binding protein 2 [5E10-3E1]

Cat. #: 158413

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Insulin-like growth factor 2 mRNA-binding protein 2

Class: Monoclonal

Application: WB ; IP

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Edward Chan

Institute: University of Florida Research Foundation

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-insulin-like growth factor-2 mRNA-binding protein 2 [5E10-3E1]
  • Alternate name: IGF2BP2
  • Research fields: Cancer;Genetics
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: WB ; IP
  • Description: IGF2BP2 is an mRNA binding protein implicated in mRNA localozation, stability, and translational control. Increased expression regulated carcinogenesis of colorectal cancer.
  • Immunogen: MAb were generated using the full length recombinant human protein as antigen.
  • Isotype: IgG1 kappa

Target Details

  • Target: Insulin-like growth factor 2 mRNA-binding protein 2
  • Target background: IGF2BP2 is an mRNA binding protein implicated in mRNA localozation, stability, and translational control. Increased expression regulated carcinogenesis of colorectal cancer.

Applications

  • Application: WB ; IP

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Shipping at 4° C

References

  • Ye et al. 2016. FEBS Lett. 590(11):1641-50. PMID: 27153315.